{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T18:11:12Z","timestamp":1657908672224},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10620-022-07386-y","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T13:02:58Z","timestamp":1644066178000},"page":"3481-3482","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid Diarrhea"],"prefix":"10.1007","volume":"67","author":[{"given":"Eric D.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"issue":"1","key":"7386_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","volume":"116","author":"BE Lacy","year":"2021","unstructured":"Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol 2021;116:17\u201344.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"7386_CR2","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.14309\/ajg.0000000000000696","volume":"115","author":"M Camilleri","year":"2020","unstructured":"Camilleri M, Vijayvargiya P. The role of bile acids in chronic diarrhea. Am J Gastroenterol 2020;115:1596\u20131603.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"7386_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/apt.15967","volume":"52","author":"M Camilleri","year":"2020","unstructured":"Camilleri M, Nord SL, Burton D, Oduyebo I, Zhang Y, Chen J et al. Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea. Aliment Pharmacol Ther 2020;52:808\u2013820.","journal-title":"Aliment Pharmacol Ther"},{"key":"7386_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.14309\/ajg.0000000000000989","volume":"116","author":"ED Shah","year":"2020","unstructured":"Shah ED, Chang L, Salwen-Deremer JK, Gibson PR, Keefer L, Muir JG et al. Contrasting clinician and insurer perspectives to managing irritable bowel syndrome: multilevel modeling analysis. Am J Gastroenterol 2020;116:748. https:\/\/doi.org\/10.14309\/ajg.0000000000000989.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"7386_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJMoa1505180","volume":"374","author":"AJ Lembo","year":"2016","unstructured":"Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA et al. Eluxadoline for irritable bowel syndrome with diarrhea. N Engl J Med 2016;374:242\u2013253.","journal-title":"N Engl J Med"},{"issue":"3","key":"7386_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bcp.2014.09.015","volume":"92","author":"W Fujita","year":"2014","unstructured":"Fujita W, Gomes I, Dove LS, Prohaska D, McIntyre G, Devi LA. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers. Biochem Pharmacol 2014;92:448\u2013456.","journal-title":"Biochem Pharmacol"},{"key":"7386_CR7","doi-asserted-by":"publisher","unstructured":"Vijayvargiya et al. Safety and efficacy of eluxadoline in patients with irritable bowel syndrome-diarrhea with or without bile acid diarrhea: open-label study. Dig Dis Sci. (Epub ahead of print). https:\/\/doi.org\/10.1007\/s10620-022-07379-x.","DOI":"10.1007\/s10620-022-07379-x"},{"issue":"1","key":"7386_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1023\/A:1026681512303","volume":"44","author":"GH Sauter","year":"1999","unstructured":"Sauter GH, M\u00fcnzing W, von Ritter C, Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci. 1999;44:14\u201319.","journal-title":"Dig Dis Sci."},{"issue":"1","key":"7386_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cgh.2019.08.062","volume":"18","author":"DC Sadowski","year":"2020","unstructured":"Sadowski DC, Camilleri M, Chey WD, Leontiadis GI, Marshall JK, Shaffer EA et al. Canadian association of gastroenterology clinical practice guideline on the management of bile acid diarrhea. Clin Gastroenterol Hepatol 2020;18:24-41.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"7386_CR10","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.gastro.2019.07.038","volume":"157","author":"W Smalley","year":"2019","unstructured":"Smalley W, Falck-Ytter C, Carrasco Labra A. AGA clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D): patient summary. Gastroenterology 2019;157:856\u2013857.","journal-title":"Gastroenterology"},{"issue":"6","key":"7386_CR11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"BE Lacy","year":"2016","unstructured":"Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M et al. Bowel disorders. Gastroenterology. 2016;150:1393-1407.e5.","journal-title":"Gastroenterology."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T17:32:06Z","timestamp":1657906326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7386"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07386-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]},"assertion":[{"value":"3 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EDS consulted for Bausch Health and GI Supply outside the scope of the current work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}